FULLTEST | |
ADVANCED PRACTICE NURSING IN THE CARE OF OLDER ADULTS 2ND
| | | | | | | | |
EDITION BY LAURIE KENNEDY-MALONE; LORI MARTIN-
| | | | | |
PLANK; EVELYN G. DUFFY | | |
PRINTED PDF I ORIGINAL DIRECTLY FROM THE PUBLISHER I 1OO%
| | | | | | | | |
|VERIFIED ANSWERS I DOWNLOAD IMMEDIATELY AFTER THE ORDER
| | | | | | |
ADVANCED PRACTICE | |
NURSING
LAURIE | KENNEDY-MALONE
LORI | MARTIN-PLANK
|EVELYN | DUFFY
Complete Test bank, All Chapters are included.
a
| | | | | |
For |more |Test |banks, |ATI, | HESI |exams, | and |more |contact |us |here:
� M | | ��
, lOMoAR | cPSD|l3O0M13o8A0R4cPSD|
| 3013804
Advanced Practice Nursing in the Care of
| | | | | |
Older Adults / Edition 2 TESTBANK
| | | | | |
Chapter 1. Changes With Aging
| | | |
Multiple |Choice
Identify |the |choice |that |best |completes |the |statement |or |answers |the |question.
1. The |major |impact |of |the |physiological |changes |that |occur |with |aging |is:
A. Reduced |physiological |reserve
B. Reduced |homeostatic |mechanisms
C. Impaired |immunological |response
D. All |of | the |above
2. The |strongest |evidence |regarding |normal |physiological |aging |is |available |through:
A. Randomized |controlled |clinical |trials
B. Cross-sectional |studies
C. Longitudinal |studies
D. Case |control |studies
3. All |of |the |following |statements |are |true |about |laboratory |values |in |older |adults |except:
A. Reference |ranges |are |preferable
B. Abnormal |findings |are |often |due |to |physiological |aging
C. Normal |ranges |may |not |be |applicable |for |older | adults
D. Reference |values |are |not |necessarily |acceptable |values
4. Biochemical |individuality |is |best |described |as:
A. Each |individual’s |variation |is |often |much |greater |than |that |of |a |larger |group
B. The |unique |biochemical |profile |of |a |selected |population
C. The |truly |“normal” |individual—falling |within |average |range
D. Each |individual’s |variation |is |often |much |smaller |than |that |of |a |larger |group
5. Polypharmacy |is |best |described |as |taking:
A. More |than |nine |medications |per |day
B. More |than |five |medications |per |day
C. Even |a |single |medication |if |there |is |not |a |clear |indication |for |its | use
D. When |a |drug |is |given |to |treat |the |side |effect |of |another | drug
6. Pharmacokinetic |changes |with |aging |is |reflective |of:
A. What |the |drug |does |to |the |body
B. What |the |body |does |to |the |drug
C. The |effect |at |the |site |of |action |and |the |time |and |intensity |of |the |drug
, lOMoAR | cPSD|
| 3013804
D. |The |side |effects |commonly |associated |with |the |drug
| | 7. |All |the |following |statements |are |false |about |drug |absorption | except:
A. Antacids |increase |the |bioavailability |of |digitalis
B. Gastric |acidity |decreases |with |age
C. Anticholinergics |increase |colonic | motility
D. Underlying |chronic |disease |has |little |impact |on |drug | absorption
| | 8. |All |of | the |following |statements |are |true |about |drug |distribution |in |the |elderly |except:
A. Drugs |distributed |in |water |have |lower | concentration
B. Drugs |distributed |in |fat |have |less |intense, |more |prolonged | effect
C. Drugs |highly |protein |bound |have |greater |potential |to |cause |an |adversedrug
reaction
|
D. The |fastest |way |to |deliver |a |drug |to |the |action |site |is |by |inhalation
| | 9. |Men |have |faster |and |more |efficient |biotransformation |of |drugs |and |this |is |thought |to |be |due | to:
A. Less |obesity |rates |than |women
B. Prostate |enlargement
C. Testosterone
D. Less |estrogen |than |women
| 10. |The |cytochrome |p |system |involves |enzymes |that |are | generally:
A. Inhibited |by |drugs
B. Induced |by |drugs
C. Inhibited |or |induced |by |drugs
D. Associated |with |decreased |liver | perfusion
| 11. |A |statement |not |shown |to |be |true |about |pharmacodynamics |changes |with |aging | is:
A. Decreased |sensitivity |to |oral |anticoagulants
B. Enhanced |sensitivity |to |central |nervous |system |drugs
C. Drug |responsiveness |can |be |influenced |by |patient |activity | level
D. There |is |a |decreased |sensitivity |to |beta | blockers
| 12. |Atypical |presentation |of |disease |in |the |elderly |is |reflected |by |all |the |following |except:
A. Infection |without |fever
B. Depression |without |dysphoric |mood
C. Myocardial |infarction |with |chest |pain |and |diaphoresis
D. Cardiac |manifestations |of |thyroid |disease
| 13. |Functional |abilities |are |best |assessed | by:
A. Self-report |of |function
B. Observed |assessment |of |function
C. A |comprehensive |head-to-toe |examination
D. Family |report |of |function
, lOMoAR | cPSD|
| 3013804
Chapter 1: Changes with Aging
| | | |
Answer Section
| |
MULTIPLE |CHOICE
1. |ANS: D PTS: 1
2. |ANS: C PTS: 1
3. |ANS: B PTS: 1
4. |ANS: D PTS: 1
5. |ANS: C PTS: 1
6. |ANS: B PTS: 1
7. |ANS: D PTS: 1
8. |ANS: A PTS: 1
9. |ANS: C PTS: 1
10. |ANS: C PTS: 1
11. |ANS: A PTS: 1
12. |ANS: C PTS: 1
13. |ANS: B PTS: 1
Chapter 2. HealthPromotion
| |
Multiple |Choice
Identify |the |choice |that |best |completes |the |statement |or |answers |the |question.
| | 1. |The |leading |cause |of |death |in |elderly |travelers |worldwide | is:
A. Cardiovascular |disease
B. Infections
C. Accidents
D. Malaria
| 2. |Which |of |the |following |should |be |avoided |in |countries |where |food |and |water |precautions |are |to |be
observed?
|
A. Hot |coffee
B. Bottled |water
C. Salad |buffet
D. Unpeeled |bananas
| | 3. |What |insect |precautions |are |not |necessary |to |prevent |insect-borne |diseases |in |the | tropics?
A. Using |100% |DEET |on |skin |to |prevent | bites
B. Treating |clothes |with |permetherin
C. Covering |up |exposed |skin |to |lessen |biting |surface
D. Taking |malaria |pills |as |directed |for |areas |at |risk |for | malaria
ADVANCED PRACTICE NURSING IN THE CARE OF OLDER ADULTS 2ND
| | | | | | | | |
EDITION BY LAURIE KENNEDY-MALONE; LORI MARTIN-
| | | | | |
PLANK; EVELYN G. DUFFY | | |
PRINTED PDF I ORIGINAL DIRECTLY FROM THE PUBLISHER I 1OO%
| | | | | | | | |
|VERIFIED ANSWERS I DOWNLOAD IMMEDIATELY AFTER THE ORDER
| | | | | | |
ADVANCED PRACTICE | |
NURSING
LAURIE | KENNEDY-MALONE
LORI | MARTIN-PLANK
|EVELYN | DUFFY
Complete Test bank, All Chapters are included.
a
| | | | | |
For |more |Test |banks, |ATI, | HESI |exams, | and |more |contact |us |here:
� M | | ��
, lOMoAR | cPSD|l3O0M13o8A0R4cPSD|
| 3013804
Advanced Practice Nursing in the Care of
| | | | | |
Older Adults / Edition 2 TESTBANK
| | | | | |
Chapter 1. Changes With Aging
| | | |
Multiple |Choice
Identify |the |choice |that |best |completes |the |statement |or |answers |the |question.
1. The |major |impact |of |the |physiological |changes |that |occur |with |aging |is:
A. Reduced |physiological |reserve
B. Reduced |homeostatic |mechanisms
C. Impaired |immunological |response
D. All |of | the |above
2. The |strongest |evidence |regarding |normal |physiological |aging |is |available |through:
A. Randomized |controlled |clinical |trials
B. Cross-sectional |studies
C. Longitudinal |studies
D. Case |control |studies
3. All |of |the |following |statements |are |true |about |laboratory |values |in |older |adults |except:
A. Reference |ranges |are |preferable
B. Abnormal |findings |are |often |due |to |physiological |aging
C. Normal |ranges |may |not |be |applicable |for |older | adults
D. Reference |values |are |not |necessarily |acceptable |values
4. Biochemical |individuality |is |best |described |as:
A. Each |individual’s |variation |is |often |much |greater |than |that |of |a |larger |group
B. The |unique |biochemical |profile |of |a |selected |population
C. The |truly |“normal” |individual—falling |within |average |range
D. Each |individual’s |variation |is |often |much |smaller |than |that |of |a |larger |group
5. Polypharmacy |is |best |described |as |taking:
A. More |than |nine |medications |per |day
B. More |than |five |medications |per |day
C. Even |a |single |medication |if |there |is |not |a |clear |indication |for |its | use
D. When |a |drug |is |given |to |treat |the |side |effect |of |another | drug
6. Pharmacokinetic |changes |with |aging |is |reflective |of:
A. What |the |drug |does |to |the |body
B. What |the |body |does |to |the |drug
C. The |effect |at |the |site |of |action |and |the |time |and |intensity |of |the |drug
, lOMoAR | cPSD|
| 3013804
D. |The |side |effects |commonly |associated |with |the |drug
| | 7. |All |the |following |statements |are |false |about |drug |absorption | except:
A. Antacids |increase |the |bioavailability |of |digitalis
B. Gastric |acidity |decreases |with |age
C. Anticholinergics |increase |colonic | motility
D. Underlying |chronic |disease |has |little |impact |on |drug | absorption
| | 8. |All |of | the |following |statements |are |true |about |drug |distribution |in |the |elderly |except:
A. Drugs |distributed |in |water |have |lower | concentration
B. Drugs |distributed |in |fat |have |less |intense, |more |prolonged | effect
C. Drugs |highly |protein |bound |have |greater |potential |to |cause |an |adversedrug
reaction
|
D. The |fastest |way |to |deliver |a |drug |to |the |action |site |is |by |inhalation
| | 9. |Men |have |faster |and |more |efficient |biotransformation |of |drugs |and |this |is |thought |to |be |due | to:
A. Less |obesity |rates |than |women
B. Prostate |enlargement
C. Testosterone
D. Less |estrogen |than |women
| 10. |The |cytochrome |p |system |involves |enzymes |that |are | generally:
A. Inhibited |by |drugs
B. Induced |by |drugs
C. Inhibited |or |induced |by |drugs
D. Associated |with |decreased |liver | perfusion
| 11. |A |statement |not |shown |to |be |true |about |pharmacodynamics |changes |with |aging | is:
A. Decreased |sensitivity |to |oral |anticoagulants
B. Enhanced |sensitivity |to |central |nervous |system |drugs
C. Drug |responsiveness |can |be |influenced |by |patient |activity | level
D. There |is |a |decreased |sensitivity |to |beta | blockers
| 12. |Atypical |presentation |of |disease |in |the |elderly |is |reflected |by |all |the |following |except:
A. Infection |without |fever
B. Depression |without |dysphoric |mood
C. Myocardial |infarction |with |chest |pain |and |diaphoresis
D. Cardiac |manifestations |of |thyroid |disease
| 13. |Functional |abilities |are |best |assessed | by:
A. Self-report |of |function
B. Observed |assessment |of |function
C. A |comprehensive |head-to-toe |examination
D. Family |report |of |function
, lOMoAR | cPSD|
| 3013804
Chapter 1: Changes with Aging
| | | |
Answer Section
| |
MULTIPLE |CHOICE
1. |ANS: D PTS: 1
2. |ANS: C PTS: 1
3. |ANS: B PTS: 1
4. |ANS: D PTS: 1
5. |ANS: C PTS: 1
6. |ANS: B PTS: 1
7. |ANS: D PTS: 1
8. |ANS: A PTS: 1
9. |ANS: C PTS: 1
10. |ANS: C PTS: 1
11. |ANS: A PTS: 1
12. |ANS: C PTS: 1
13. |ANS: B PTS: 1
Chapter 2. HealthPromotion
| |
Multiple |Choice
Identify |the |choice |that |best |completes |the |statement |or |answers |the |question.
| | 1. |The |leading |cause |of |death |in |elderly |travelers |worldwide | is:
A. Cardiovascular |disease
B. Infections
C. Accidents
D. Malaria
| 2. |Which |of |the |following |should |be |avoided |in |countries |where |food |and |water |precautions |are |to |be
observed?
|
A. Hot |coffee
B. Bottled |water
C. Salad |buffet
D. Unpeeled |bananas
| | 3. |What |insect |precautions |are |not |necessary |to |prevent |insect-borne |diseases |in |the | tropics?
A. Using |100% |DEET |on |skin |to |prevent | bites
B. Treating |clothes |with |permetherin
C. Covering |up |exposed |skin |to |lessen |biting |surface
D. Taking |malaria |pills |as |directed |for |areas |at |risk |for | malaria
